| immune effector process | GO:0002252 | 321 | 0.593 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.581 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.571 | |
| adaptive immune response | GO:0002250 | 155 | 0.559 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.537 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.491 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.374 | |
| b cell activation | GO:0042113 | 161 | 0.361 | |
| defense response to other organism | GO:0098542 | 197 | 0.328 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.300 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.279 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.257 | |
| regulation of cell activation | GO:0050865 | 289 | 0.256 | |
| purinergic nucleotide receptor signaling pathway | GO:0035590 | 3 | 0.255 | |
| cytokine production | GO:0001816 | 319 | 0.236 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.233 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.215 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.215 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.213 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.211 | |
| cellular response to lipid | GO:0071396 | 145 | 0.210 | |
| metanephric glomerular visceral epithelial cell development | GO:0072249 | 2 | 0.205 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.198 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.196 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.186 | |
| regulation of type iia hypersensitivity | GO:0001796 | 4 | 0.183 | |
| activation of immune response | GO:0002253 | 138 | 0.177 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.176 | |
| negative regulation of hypersensitivity | GO:0002884 | 3 | 0.172 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.172 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.170 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.162 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.160 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.158 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.141 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.136 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.132 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.130 | |
| regulation of defense response | GO:0031347 | 233 | 0.125 | |
| adiponectin secretion | GO:0070162 | 2 | 0.121 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.119 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.118 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.113 | |
| positive regulation of type iii hypersensitivity | GO:0001805 | 3 | 0.113 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.113 | |
| type i hypersensitivity | GO:0016068 | 4 | 0.112 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.109 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.109 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.108 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.105 | |
| thrombin receptor signaling pathway | GO:0070493 | 2 | 0.101 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.101 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.101 | |
| erythropoietin mediated signaling pathway | GO:0038162 | 1 | 0.100 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.099 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.099 | |
| mast cell activation | GO:0045576 | 27 | 0.099 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.099 | |
| positive regulation of natural killer cell chemotaxis | GO:2000503 | 1 | 0.099 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.099 | |
| maintenance of location | GO:0051235 | 89 | 0.097 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.097 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.096 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.096 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.094 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.094 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.093 | |
| immunoglobulin production | GO:0002377 | 73 | 0.087 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.086 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.086 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.085 | |
| glomerulus development | GO:0032835 | 40 | 0.084 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.082 | |
| mast cell mediated immunity | GO:0002448 | 20 | 0.082 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.081 | |
| regulated secretory pathway | GO:0045055 | 32 | 0.081 | |
| inflammatory response | GO:0006954 | 244 | 0.081 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.081 | |
| g protein coupled purinergic nucleotide receptor signaling pathway | GO:0035589 | 1 | 0.080 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.080 | |
| detection of yeast | GO:0001879 | 2 | 0.080 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.079 | |
| membrane organization | GO:0061024 | 245 | 0.076 | |
| positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process | GO:0045425 | 2 | 0.076 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.076 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.075 | |
| t cell differentiation | GO:0030217 | 174 | 0.074 | |
| regulation of protein transport | GO:0051223 | 163 | 0.074 | |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.074 | |
| amine metabolic process | GO:0009308 | 45 | 0.074 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.072 | |
| regulation of mast cell activation | GO:0033003 | 21 | 0.072 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.071 | |
| chemotaxis | GO:0006935 | 247 | 0.070 | |
| regulation of type iii hypersensitivity | GO:0001803 | 3 | 0.070 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.069 | |
| fc epsilon receptor signaling pathway | GO:0038095 | 3 | 0.067 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.067 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.066 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.066 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.065 | |
| endocytosis | GO:0006897 | 168 | 0.065 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.064 | |
| t cell proliferation | GO:0042098 | 120 | 0.063 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.063 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.062 | |
| myotube differentiation | GO:0014902 | 105 | 0.062 | |
| innate immune response | GO:0045087 | 157 | 0.062 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 9 | 0.061 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.060 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.060 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.059 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.059 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.058 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.058 | |
| metanephric glomerular visceral epithelial cell differentiation | GO:0072248 | 2 | 0.057 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.057 | |
| cytokine secretion | GO:0050663 | 72 | 0.056 | |
| activation of innate immune response | GO:0002218 | 56 | 0.056 | |
| mapk cascade | GO:0000165 | 281 | 0.056 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.056 | |
| oxidation reduction process | GO:0055114 | 342 | 0.055 | |
| positive regulation of dendritic cell dendrite assembly | GO:2000549 | 1 | 0.055 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.055 | |
| regulation of type i hypersensitivity | GO:0001810 | 4 | 0.054 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.054 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.053 | |
| positive regulation of dna biosynthetic process | GO:2000573 | 4 | 0.053 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.053 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.052 | |
| protein autoprocessing | GO:0016540 | 2 | 0.052 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.052 | |
| midgut development | GO:0007494 | 4 | 0.051 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.051 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.051 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.051 | |
| nephron development | GO:0072006 | 109 | 0.049 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.049 | |
| phagocytosis | GO:0006909 | 66 | 0.049 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.048 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.048 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.048 | |
| unsaturated fatty acid biosynthetic process | GO:0006636 | 15 | 0.048 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.048 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.047 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.047 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.047 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.046 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.046 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.046 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.046 | |
| activation of mapk activity | GO:0000187 | 59 | 0.046 | |
| regulation of secretion | GO:0051046 | 274 | 0.046 | |
| fat cell differentiation | GO:0045444 | 160 | 0.046 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.046 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.046 | |
| cell killing | GO:0001906 | 67 | 0.046 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.045 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.045 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.045 | |
| cell cell adhesion | GO:0098609 | 41 | 0.044 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.044 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.044 | |
| leukocyte degranulation | GO:0043299 | 27 | 0.044 | |
| metanephric glomerular epithelial cell development | GO:0072313 | 2 | 0.044 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.044 | |
| negative regulation of inflammatory response to antigenic stimulus | GO:0002862 | 10 | 0.044 | |
| lipid modification | GO:0030258 | 65 | 0.043 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.043 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.043 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.043 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.043 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.043 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.043 | |
| cellular homeostasis | GO:0019725 | 240 | 0.043 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.043 | |
| negative regulation of gluconeogenesis | GO:0045721 | 9 | 0.042 | |
| kidney development | GO:0001822 | 213 | 0.042 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.042 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.042 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.041 | |
| cell adhesion | GO:0007155 | 329 | 0.041 | |
| chemokine secretion | GO:0090195 | 5 | 0.041 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.041 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.040 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.040 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.040 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.040 | |
| cell chemotaxis | GO:0060326 | 81 | 0.039 | |
| cation transport | GO:0006812 | 399 | 0.039 | |
| cell surface pattern recognition receptor signaling pathway | GO:0002752 | 2 | 0.038 | |
| actin filament organization | GO:0007015 | 113 | 0.038 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.038 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.038 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.038 | |
| eosinophil migration | GO:0072677 | 3 | 0.038 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.038 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.038 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.038 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.038 | |
| response to peptide | GO:1901652 | 136 | 0.037 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.037 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.037 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.037 | |
| regulation of protein localization | GO:0032880 | 231 | 0.037 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.037 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.036 | |
| protein secretion | GO:0009306 | 111 | 0.036 | |
| t cell activation | GO:0042110 | 289 | 0.036 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.036 | |
| cell migration involved in kidney development | GO:0035787 | 3 | 0.036 | |
| regulation of cell migration | GO:0030334 | 219 | 0.036 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.036 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.036 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.036 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.035 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.035 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.035 | |
| response to drug | GO:0042493 | 75 | 0.035 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.034 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.034 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.034 | |
| renal system development | GO:0072001 | 225 | 0.034 | |
| glucose transport | GO:0015758 | 56 | 0.034 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.034 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.033 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.033 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.033 | |
| cellular response to peptidoglycan | GO:0071224 | 4 | 0.033 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.033 | |
| cell recognition | GO:0008037 | 83 | 0.033 | |
| renal protein absorption | GO:0097017 | 1 | 0.033 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.033 | |
| lysosome localization | GO:0032418 | 20 | 0.032 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.032 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.032 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.032 | |
| monosaccharide transport | GO:0015749 | 58 | 0.032 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.032 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.032 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.032 | |
| exocytosis | GO:0006887 | 121 | 0.031 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.031 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.031 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.031 | |
| defense response to bacterium | GO:0042742 | 119 | 0.031 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.031 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.031 | |
| developmental maturation | GO:0021700 | 193 | 0.031 | |
| defense response to virus | GO:0051607 | 68 | 0.031 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.030 | |
| positive regulation of t helper 2 cell cytokine production | GO:2000553 | 3 | 0.030 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.030 | |
| protein localization to organelle | GO:0033365 | 185 | 0.030 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.030 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.030 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.030 | |
| urogenital system development | GO:0001655 | 261 | 0.030 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.030 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.030 | |
| response to thyroid hormone | GO:0097066 | 2 | 0.030 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.029 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.029 | |
| regulation of type ii hypersensitivity | GO:0002892 | 4 | 0.029 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.029 | |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0014808 | 12 | 0.029 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.029 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.029 | |
| placenta development | GO:0001890 | 140 | 0.029 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.029 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.028 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.028 | |
| olfactory learning | GO:0008355 | 2 | 0.028 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.028 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.028 | |
| response to oxidative stress | GO:0006979 | 123 | 0.028 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.027 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.027 | |
| immune response inhibiting cell surface receptor signaling pathway | GO:0002767 | 3 | 0.027 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.027 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.027 | |
| organic anion transport | GO:0015711 | 137 | 0.027 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.027 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.027 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.027 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.027 | |
| positive regulation of type 2 immune response | GO:0002830 | 9 | 0.027 | |
| regulation of immunoglobulin production in mucosal tissue | GO:2000557 | 1 | 0.026 | |
| wound healing | GO:0042060 | 157 | 0.026 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.026 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.026 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.026 | |
| regulation of mast cell activation involved in immune response | GO:0033006 | 17 | 0.026 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.026 | |
| detection of oxidative stress | GO:0070994 | 1 | 0.025 | |
| positive regulation of metanephric glomerular visceral epithelial cell development | GO:2000478 | 1 | 0.025 | |
| regulation of system process | GO:0044057 | 200 | 0.025 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | |
| detection of stimulus | GO:0051606 | 84 | 0.025 | |
| positive regulation of glomerulus development | GO:0090193 | 5 | 0.025 | |
| respiratory tube development | GO:0030323 | 167 | 0.025 | |
| innate immune response activating cell surface receptor signaling pathway | GO:0002220 | 4 | 0.025 | |
| angiogenesis | GO:0001525 | 201 | 0.025 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.025 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.025 | |
| positive regulation of muscle adaptation | GO:0014744 | 2 | 0.025 | |
| basal protein localization | GO:0045175 | 1 | 0.025 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.025 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.024 | |
| positive regulation of g1 s transition of mitotic cell cycle | GO:1900087 | 9 | 0.024 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.024 | |
| jnk cascade | GO:0007254 | 72 | 0.024 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.024 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.024 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.024 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.024 | |
| glucose homeostasis | GO:0042593 | 128 | 0.024 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.024 | |
| spermatogenesis | GO:0007283 | 284 | 0.024 | |
| leukocyte migration | GO:0050900 | 124 | 0.024 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.024 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.024 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.024 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.023 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.023 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.023 | |
| cognition | GO:0050890 | 149 | 0.023 | |
| response to steroid hormone | GO:0048545 | 56 | 0.023 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.023 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.023 | |
| negative regulation of type i hypersensitivity | GO:0001811 | 1 | 0.023 | |
| cellular response to drug | GO:0035690 | 15 | 0.023 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.023 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.022 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.022 | |
| positive regulation of leukocyte degranulation | GO:0043302 | 10 | 0.022 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.022 | |
| response to corticosteroid | GO:0031960 | 20 | 0.022 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.022 | |
| humoral immune response | GO:0006959 | 57 | 0.022 | |
| response to interferon gamma | GO:0034341 | 34 | 0.022 | |
| type 2 immune response | GO:0042092 | 23 | 0.022 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.022 | |
| regulation of kidney development | GO:0090183 | 40 | 0.022 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.022 | |
| positive regulation of chemokine production | GO:0032722 | 22 | 0.022 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.022 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.022 | |
| antibody dependent cellular cytotoxicity | GO:0001788 | 2 | 0.022 | |
| positive regulation of myotube differentiation | GO:0010831 | 24 | 0.021 | |
| synapse organization | GO:0050808 | 125 | 0.021 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.021 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.021 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.021 | |
| syncytium formation | GO:0006949 | 43 | 0.021 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.021 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.021 | |
| positive regulation of mast cell degranulation | GO:0043306 | 10 | 0.021 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.021 | |
| positive regulation of chemokine secretion | GO:0090197 | 4 | 0.021 | |
| lung development | GO:0030324 | 164 | 0.021 | |
| regulation of cell motility | GO:2000145 | 236 | 0.021 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.021 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.021 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.021 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.021 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.021 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.021 | |
| negative regulation of metanephric mesenchymal cell migration | GO:2000590 | 1 | 0.021 | |
| germ cell development | GO:0007281 | 185 | 0.020 | |
| regulation of epithelial cell differentiation involved in kidney development | GO:2000696 | 10 | 0.020 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.020 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.020 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.020 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.020 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.020 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.020 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.020 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.020 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.020 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.019 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.019 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.019 | |
| humoral immune response mediated by circulating immunoglobulin | GO:0002455 | 14 | 0.019 | |
| regulation of immunoglobulin production | GO:0002637 | 42 | 0.019 | |
| neuron death | GO:0070997 | 154 | 0.019 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.019 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.019 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.019 | |
| positive regulation of synapse assembly | GO:0051965 | 18 | 0.019 | |
| metanephros development | GO:0001656 | 79 | 0.019 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.019 | |
| positive regulation of syncytium formation by plasma membrane fusion | GO:0060143 | 17 | 0.019 | |
| regulation of renal albumin absorption | GO:2000532 | 1 | 0.019 | |
| regulation of t helper 1 cell cytokine production | GO:2000554 | 1 | 0.019 | |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.019 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.019 | |
| lipid catabolic process | GO:0016042 | 69 | 0.019 | |
| hormone secretion | GO:0046879 | 128 | 0.019 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.018 | |
| calcium ion transport | GO:0006816 | 159 | 0.018 | |
| mast cell degranulation | GO:0043303 | 19 | 0.018 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.018 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.018 | |
| regulation of toll like receptor 9 signaling pathway | GO:0034163 | 3 | 0.018 | |
| response to radiation | GO:0009314 | 165 | 0.018 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.018 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.018 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.018 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class i | GO:0042590 | 6 | 0.018 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.018 | |
| ear development | GO:0043583 | 200 | 0.018 | |
| histamine production involved in inflammatory response | GO:0002349 | 1 | 0.018 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.018 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.018 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.018 | |
| response to morphine | GO:0043278 | 9 | 0.018 | |
| cellularization | GO:0007349 | 1 | 0.017 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.017 | |
| muscle tissue development | GO:0060537 | 308 | 0.017 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.017 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.017 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.017 | |
| nitric oxide metabolic process | GO:0046209 | 25 | 0.017 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.017 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.017 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.017 | |
| ossification | GO:0001503 | 216 | 0.017 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.017 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.017 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.017 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.017 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.017 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.017 | |
| thymocyte migration | GO:0072679 | 2 | 0.017 | |
| phagocytosis recognition | GO:0006910 | 12 | 0.017 | |
| protein catabolic process | GO:0030163 | 221 | 0.017 | |
| skeletal system development | GO:0001501 | 356 | 0.017 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.017 | |
| regulation of ossification | GO:0030278 | 112 | 0.017 | |
| tissue homeostasis | GO:0001894 | 115 | 0.017 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.017 | |
| macrophage migration inhibitory factor signaling pathway | GO:0035691 | 2 | 0.017 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.017 | |
| male gamete generation | GO:0048232 | 285 | 0.017 | |
| positive regulation of type iia hypersensitivity | GO:0001798 | 4 | 0.017 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.017 | |
| regulation of g protein coupled receptor protein signaling pathway | GO:0008277 | 37 | 0.017 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.016 | |
| hypersensitivity | GO:0002524 | 10 | 0.016 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.016 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.016 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.016 | |
| protein processing | GO:0016485 | 163 | 0.016 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.016 | |
| response to peptide hormone | GO:0043434 | 127 | 0.016 | |
| sensory perception | GO:0007600 | 245 | 0.016 | |
| cell maturation | GO:0048469 | 127 | 0.016 | |
| negative regulation of adaptive immune response | GO:0002820 | 25 | 0.016 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.016 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.016 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.016 | |
| positive regulation of macrophage chemotaxis | GO:0010759 | 5 | 0.016 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.016 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.016 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.016 | |
| smooth muscle cell chemotaxis | GO:0071670 | 2 | 0.016 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.016 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.016 | |
| oxygen metabolic process | GO:0072592 | 4 | 0.016 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.016 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.016 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.016 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.016 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.016 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.015 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.015 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.015 | |
| antigen processing and presentation of peptide antigen | GO:0048002 | 29 | 0.015 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.015 | |
| cell differentiation involved in metanephros development | GO:0072202 | 12 | 0.015 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.015 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.015 | |
| positive regulation of cell killing | GO:0031343 | 33 | 0.015 | |
